TriSalus Life Sciences Inc. Financial Flexibility Index
TriSalus Life Sciences Inc. financial flexibility index. TriSalus Life Sciences Inc. (TLSI) has a Financial Flexibility Index of -0.29x as of June 2026. Free cash flow of $-16.39 Million (operating CF $-16.61 Million minus capex $223.00K) represents 0% of total liabilities ($55.90 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of TriSalus Life Sciences Inc. (2021–2025)
Financial flexibility index of TriSalus Life Sciences Inc. from 2021 to 2025. Historical Financial Flexibility Index trend for TriSalus Life Sciences Inc. across 5 annual periods. Check earnings quality score of TriSalus Life Sciences Inc. to evaluate the quality of earnings relative to operating cash generation.
TriSalus Life Sciences Inc. Financial Flexibility Index by Year (2021–2025)
TriSalus Life Sciences Inc. financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for TriSalus Life Sciences Inc.. For the full cash flow conversion analysis, see TLSI cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.25x | $-17.09 Million | $-18.01 Million | $69.19 Million | ▲ +69.6% |
| 2024 | -0.81x | $-40.50 Million | $-40.84 Million | $49.87 Million | ▲ +16.1% |
| 2023 | -0.97x | $-49.99 Million | $-50.58 Million | $51.66 Million | ▼ -5.3% |
| 2022 | -0.92x | $-31.53 Million | $-32.31 Million | $34.32 Million | ▲ +70.3% |
| 2021 | -3.09x | $-21.44 Million | $-22.70 Million | $6.93 Million | — |